MX2024002959A - Adaptacion de hospedadores de plataforma a medios igf-. - Google Patents

Adaptacion de hospedadores de plataforma a medios igf-.

Info

Publication number
MX2024002959A
MX2024002959A MX2024002959A MX2024002959A MX2024002959A MX 2024002959 A MX2024002959 A MX 2024002959A MX 2024002959 A MX2024002959 A MX 2024002959A MX 2024002959 A MX2024002959 A MX 2024002959A MX 2024002959 A MX2024002959 A MX 2024002959A
Authority
MX
Mexico
Prior art keywords
sup
igf
media
adaptation
platform hosts
Prior art date
Application number
MX2024002959A
Other languages
English (en)
Spanish (es)
Inventor
Trent Phillip Munro
Huong Thi Ngoc Le
Kristine Marie Daris
Eric Gislason
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2024002959A publication Critical patent/MX2024002959A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/105Insulin-like growth factors [IGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
MX2024002959A 2021-09-10 2022-09-09 Adaptacion de hospedadores de plataforma a medios igf-. MX2024002959A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163242623P 2021-09-10 2021-09-10
PCT/US2022/076158 WO2023039502A1 (en) 2021-09-10 2022-09-09 Adaptation of platform hosts to igf- media

Publications (1)

Publication Number Publication Date
MX2024002959A true MX2024002959A (es) 2024-03-27

Family

ID=84053053

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024002959A MX2024002959A (es) 2021-09-10 2022-09-09 Adaptacion de hospedadores de plataforma a medios igf-.

Country Status (13)

Country Link
US (1) US20230082811A1 (https=)
EP (1) EP4399225A1 (https=)
JP (1) JP2024533319A (https=)
KR (1) KR20240054986A (https=)
CN (1) CN117897401A (https=)
AR (1) AR127022A1 (https=)
AU (1) AU2022344262A1 (https=)
CA (1) CA3230418A1 (https=)
CL (1) CL2024000698A1 (https=)
IL (1) IL310660A (https=)
MX (1) MX2024002959A (https=)
TW (1) TW202328442A (https=)
WO (1) WO2023039502A1 (https=)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
US6319494B1 (en) 1990-12-14 2001-11-20 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化b−b10
US5262308A (en) * 1992-01-28 1993-11-16 Thomas Jefferson University Cell lines which constitutively express IGF-1 and IGF-1 R
IL104570A0 (en) 1992-03-18 1993-05-13 Yeda Res & Dev Chimeric genes and cells transformed therewith
ES2227669T3 (es) 1996-01-11 2005-04-01 Immunex Corporation Elementos de secuencia que aumentan la expresion (ease) para sistemas de expresion de eurocariotas.
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
GB9928787D0 (en) 1999-12-03 2000-02-02 Medical Res Council Direct screening method
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
GB0025144D0 (en) 2000-10-13 2000-11-29 Medical Res Council Concatenated nucleic acid sequences
US20040202995A1 (en) 2003-04-09 2004-10-14 Domantis Nucleic acids, proteins, and screening methods
EP1614755A1 (en) 2004-07-07 2006-01-11 ARTEMIS Pharmaceuticals GmbH Target transgenesis of short hairpin RNA expression cassette using recombinase mediated cassette exchange
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
US20070231895A1 (en) * 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
AU2007294731B2 (en) * 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
WO2008154014A2 (en) 2007-06-11 2008-12-18 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
SG191561A1 (en) 2008-08-22 2013-07-31 Sangamo Biosciences Inc Methods and compositions for targeted single-stranded cleavage and targeted integration
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
JP6195191B2 (ja) 2013-08-08 2017-09-13 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株を用いた組換えタンパク質の製造方法
US10973069B2 (en) 2017-08-07 2021-04-06 Lg Electronics Inc. Method and apparatus for keeping DC configuration
EP3441471A1 (en) * 2017-08-08 2019-02-13 CEVEC Pharmaceuticals GmbH Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines

Also Published As

Publication number Publication date
AU2022344262A1 (en) 2024-02-22
CN117897401A (zh) 2024-04-16
AR127022A1 (es) 2023-12-13
IL310660A (en) 2024-04-01
CA3230418A1 (en) 2023-03-16
US20230082811A1 (en) 2023-03-16
CL2024000698A1 (es) 2024-09-06
JP2024533319A (ja) 2024-09-12
KR20240054986A (ko) 2024-04-26
WO2023039502A1 (en) 2023-03-16
TW202328442A (zh) 2023-07-16
EP4399225A1 (en) 2024-07-17

Similar Documents

Publication Publication Date Title
CU23382A3 (es) Metodo de producir celulas utiles para la expresion de una proteina heterologa
WO2012008813A3 (ko) 양막유래 중간엽 줄기세포 배양을 위한 배지조성물 및 이를 이용한 양막유래 중간엽 줄기세포의 배양방법
MX2012003654A (es) Metodos de produccion de glucoproteinas en cultivos de celulas de mamiferos usando glucocorticoides.
RU2008152449A (ru) Получение гликопротеинов
IL222452B (en) A process for preparing a recombinant polypeptide by growing mammalian cells in a serum-free and protein-free cell culture medium
WO2005028626A3 (en) Cell culture media
RU2010128902A (ru) Композиции и способы получения изопрена
EP4368699A3 (en) Methods of producing recombinant proteins
MX2024002959A (es) Adaptacion de hospedadores de plataforma a medios igf-.
JP2021529527A5 (https=)
CA2796599A1 (en) Method for producing induced pluripotent stem cells
CN119955840B (zh) 一种增强酿酒酵母对冷冻的耐受能力的方法
CN106916775A (zh) 高产纳米多聚磷酸体的转基因藻株及其制备方法
MX2023004885A (es) Sobreexpresión de mutantes del receptor de factor de crecimiento insulinico para modular la suplementación de igf.
CN1243094C (zh) 脐血间充质干细胞支持造血干/祖细胞体外扩增方法
CN118638212A (zh) 一种烟草表达的重组人源ⅲ型胶原蛋白及其编码基因和制备方法
CN112824530A (zh) 一种hek293f悬浮细胞高效电转染方法
CN119630690A (zh) 改进的生产细胞
MX2023008527A (es) Metodos para mejorar el valor proteico en cultivo celular.
WO2023194488A1 (en) Large scale manufacturing of ipsc derived hsc and progeny
CN102690836A (zh) 转基因絮凝微藻的构建及其在微藻采收中的应用
CN113462636B (zh) 一种表皮干细胞向肝脏细胞分化的改进方法
Kim et al. Recent advances and strategies in cultured satellite cell cultivation for efficient cultured meat production: A review
RU2012109240A (ru) Способ культивирования мышечных клеток in vitro для получения биомассы, используемой для производства мясных пищевых продуктов
CN113862217A (zh) 培养哺乳动物细胞的方法